StemBioSys
PrivateLast Round
Series C
Extension
Jun 5, 2024
Est. Valuation
$52.95M
Total Funding Raised
$20.8M
Company Overview
StemBioSys operates in Healthcare & Life Sciences and is based in San Antonio, Texas. Its latest recorded funding round was a Series C round in August 2021.
StemBioSys is a biotechnology company that develops cell-matrix technologies designed for the enhanced isolation, growth, and delivery of stem cells for research, diagnostic, and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StemBioSys Comparables
Compare StemBioSys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioLamina AB | 83% | |
| Xylyx Bio | 79% | |
| Bio-Techne Corporation | 77% |
For institutional investors. Book with your work email.
StemBioSys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jun 5, 2024 | ||||
| Series C | Aug 1, 2021 | ||||
| Grant | Apr 30, 2019 | ||||
| Grant | Apr 30, 2019 | ||||
| Series B | May 24, 2018 | ||||
Series A | Apr 14, 2015 |
For institutional investors. Book with your work email.
StemBioSys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VelocityTX | Pre Seed |
| National Institute on Aging | Grant |
| National Institute of Environmental Health Sciences | Grant |
| Targeted Technology | Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2025
Monthly visitors grew 108% MoM, reaching 2.5K.
- Nov 24, 2024
Monthly visitors grew 93% MoM, reaching 2.7K.
For institutional investors. Book with your work email.
StemBioSys Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about StemBioSys's valuation, stock price, and market status.
Is StemBioSys a public or private company?
StemBioSys is a private company.
What is the current stock price of StemBioSys?
StemBioSys is a private company, so its shares have no public market price. Caplight tracks StemBioSys's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is StemBioSys worth (valuation)?
StemBioSys's valuation is estimated at $53.0M based on funding round data.
Can I buy StemBioSys stock?
StemBioSys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was StemBioSys's last funding round?
StemBioSys's most recent funding round was Series C Extension on June 5, 2024.
Who are the main investors in StemBioSys?
Key investors in StemBioSys include Targeted Technology.
Will StemBioSys IPO soon?
No public IPO plans have been announced for StemBioSys.
How can I track StemBioSys secondary market activity?
Caplight tracks bids, offers, and trades in StemBioSys's shares on secondary markets.